MX9307410A - Cepa de streptomyces para producir compuestos antiparasitos y procedimiento para producir tales compuestos. - Google Patents

Cepa de streptomyces para producir compuestos antiparasitos y procedimiento para producir tales compuestos.

Info

Publication number
MX9307410A
MX9307410A MX9307410A MX9307410A MX9307410A MX 9307410 A MX9307410 A MX 9307410A MX 9307410 A MX9307410 A MX 9307410A MX 9307410 A MX9307410 A MX 9307410A MX 9307410 A MX9307410 A MX 9307410A
Authority
MX
Mexico
Prior art keywords
compounds
produce
antiparasites
procedure
streptomyces strain
Prior art date
Application number
MX9307410A
Other languages
English (en)
Inventor
Raymond Che-Fong Yao
Rosanne Bonjouklian
Otis Webster Godfrey Jr
Tim Allen Smitka
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9307410A publication Critical patent/MX9307410A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención proporciona un nuevo microorganismo, Streptomyces avermitilis subespecie niger NRRL 21005, y procedimiento para producir avermectinas conocidas.
MX9307410A 1992-11-30 1993-11-25 Cepa de streptomyces para producir compuestos antiparasitos y procedimiento para producir tales compuestos. MX9307410A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/984,078 US5292647A (en) 1992-11-30 1992-11-30 Strain of streptomyces for producing avermectins and processes therewith

Publications (1)

Publication Number Publication Date
MX9307410A true MX9307410A (es) 1994-07-29

Family

ID=25530287

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307410A MX9307410A (es) 1992-11-30 1993-11-25 Cepa de streptomyces para producir compuestos antiparasitos y procedimiento para producir tales compuestos.

Country Status (21)

Country Link
US (1) US5292647A (es)
EP (1) EP0600656A3 (es)
JP (1) JPH06237761A (es)
KR (1) KR940011630A (es)
CN (1) CN1088983A (es)
AU (1) AU667141B2 (es)
BR (1) BR9304843A (es)
CA (1) CA2109767A1 (es)
CO (1) CO4130314A1 (es)
CZ (1) CZ282908B6 (es)
FI (1) FI935246A (es)
HU (1) HUT69970A (es)
IL (1) IL107702A (es)
MX (1) MX9307410A (es)
MY (1) MY109797A (es)
NO (1) NO934293L (es)
NZ (1) NZ250247A (es)
PH (1) PH30116A (es)
PL (1) PL301204A1 (es)
RU (1) RU2125609C1 (es)
ZA (1) ZA938723B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100419554B1 (ko) * 1999-10-29 2004-02-19 주식회사유한양행 아버멕틴의 정제방법
US7651233B2 (en) * 2004-01-08 2010-01-26 Sharp Kabushiki Kaisha Lighting device for display devices, liquid crystal display device, and light source lamp
CN100448984C (zh) * 2006-03-07 2009-01-07 广东省微生物研究所 粤蓝链霉菌
CN102016054A (zh) * 2008-04-25 2011-04-13 株式会社太平洋 用生物转化系统制备正二羟基异黄酮的方法
CN102443555B (zh) * 2011-11-16 2013-04-24 南开大学 链霉菌Streptomyces sp.NK-660及其用于生产ε-聚赖氨酸的发酵培养方法
WO2017052232A1 (ko) * 2015-09-22 2017-03-30 주식회사 팜한농 밀베마이신을 생산하는 재조합 미생물 및 이를 이용한 밀베마이신 생산
KR102017788B1 (ko) * 2017-09-18 2019-09-03 주식회사 팜한농 밀베마이신 d를 생산하는 재조합 미생물 및 밀베마이신 d 생산 방법
CN114075527B (zh) * 2021-10-25 2024-03-26 成都大学 一种脂溶性抗生素生物发酵调控的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
US4378353A (en) * 1981-02-17 1983-03-29 Merck & Co., Inc. Novel C-076 compounds
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
ES2058244T3 (es) * 1987-01-23 1994-11-01 Pfizer Procedimiento para produccion de avermectinas y cultivos para el mismo.
IN167980B (es) * 1987-01-23 1991-01-19 Pfizer
US5015662A (en) * 1988-10-18 1991-05-14 Merck & Co., Inc. Anthelmintic bioconversion products
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Also Published As

Publication number Publication date
EP0600656A3 (en) 1995-07-05
FI935246A (fi) 1994-05-31
BR9304843A (pt) 1994-06-14
CN1088983A (zh) 1994-07-06
IL107702A (en) 1998-10-30
RU2125609C1 (ru) 1999-01-27
HUT69970A (en) 1995-09-28
CZ282908B6 (cs) 1997-11-12
NZ250247A (en) 1994-12-22
AU667141B2 (en) 1996-03-07
JPH06237761A (ja) 1994-08-30
US5292647A (en) 1994-03-08
FI935246A0 (fi) 1993-11-25
CZ250293A3 (en) 1994-06-15
KR940011630A (ko) 1994-06-21
PL301204A1 (en) 1994-06-13
AU5196093A (en) 1994-06-09
CO4130314A1 (es) 1995-02-13
MY109797A (en) 1997-07-31
EP0600656A2 (en) 1994-06-08
ZA938723B (en) 1995-05-22
NO934293L (no) 1994-05-31
NO934293D0 (no) 1993-11-26
CA2109767A1 (en) 1994-05-31
HU9303366D0 (en) 1994-03-28
IL107702A0 (en) 1994-02-27
PH30116A (en) 1996-12-27

Similar Documents

Publication Publication Date Title
EP0671902A4 (en) THERAPY OF TOXI-INFECTIONS WITH -i (CLOSTRIDIUM).
TW278099B (es)
ZA925771B (en) Method and apparatus for manufacturing mineral wool, and mineral wool produced thereby.
AU7327596A (en) Preparation of phosphorothioate oligomers
EP1147775A3 (en) Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
MX9307410A (es) Cepa de streptomyces para producir compuestos antiparasitos y procedimiento para producir tales compuestos.
MX9801017A (es) Logica anti-caza.
EP0657438A3 (en) Process for the preparation of alkylulfinylbenzamides and 1,2-benzoisothiazol-3-ones.
NO163574C (no) Fremgangsmaate for fremstilling av antitumor-antibiotika (ll-e33288 kompleks) ved fermentering av micromonospora echinospora ssp. calichensis nrrl 1539 og nrrl 15975.
AU633069B2 (en) Targeted forms of methyltrithio antitumor agents
AU548912B2 (en) Gas tempering at super atmospheric pressure
CA2094424A1 (en) Method of treating osteoporosis with 1.alpha.,24(r)-dihydroxy-22(e)-dehydro-vitamin d3
DE3372214D1 (en) Process for producing vitamin b12 by the fermentation technique, and vitamin b12-producing microorganism
CA2131087A1 (fr) Souches de streptomyces et methodes produisant selectivement une seule composante d'une streptogramine
PL313322A1 (en) Method of obtaining 9-(2-hydroxy)etyhoxymethylquanine
DE3663780D1 (en) Method to roll multiple sections
RU93052142A (ru) Штамм стрептомицетов для продуцирования антипаразитарных соединений и способы продуцирования этих соединений
IE812615L (en) Deesterifying enzyme
JPS5410860A (en) Rolling friction planetary roller system
ZA815330B (en) New antibiotic,mf 266 substance and production thereof
GR3032649T3 (en) CATALASE-BASED ANTI--i(HELICOBACTER PYLORI) IMMUNISING COMPOSITION
JPS57105192A (en) Production of acranomycine compound
AU1076595A (en) Intestinal flora improver composition, and apparatus and system for producing the same
AU2629792A (en) Process for the purification of streptolysin 0, intact streptolysin 0 obtained by this process and its use

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees